Insider · CIK 0001606653

Kenney Richard T

Reports to the SEC for 2 companies · SEATTLE, WA

sec.gov

Transactions

Companies

Filings

CIK

0001606653

Forms 4 and 5

Insider transactions

24 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-12-02	Sonnet BioTherapeutics Holdings, Inc.D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−9,374 sh	—	—	0
2025-12-02	Sonnet BioTherapeutics Holdings, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+86.5K sh	—	—	86,505
2025-12-02	Sonnet BioTherapeutics Holdings, Inc.F Tax Payment	Chief Medical Officer	FTax Payment	−16.9K sh	—	—	69,614
2025-12-02	Sonnet BioTherapeutics Holdings, Inc.D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−69.6K sh	—	—	0
2025-12-02	Sonnet BioTherapeutics Holdings, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+164K sh	—	—	163,760
2025-12-02	Sonnet BioTherapeutics Holdings, Inc.D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−164K sh	—	—	0
2025-12-02	Sonnet BioTherapeutics Holdings, Inc.Warrant (Common Stock)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−86.5K sh	—	—	0
2025-12-02	Sonnet BioTherapeutics Holdings, Inc.Warrant (Common Stock)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−320K sh	—	—	0
2025-12-02	Sonnet BioTherapeutics Holdings, Inc.Series 5 Preferred StockM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−200 sh	—	—	0
2025-07-14	Sonnet BioTherapeutics Holdings, Inc.WarrantA Award	Chief Medical Officer	AAward	+320K sh	—	—	320,000
2025-07-14	Sonnet BioTherapeutics Holdings, Inc.Series 5 Preferred StockA Award	Chief Medical Officer	AAward	+200 sh	—	—	200
2025-07-11	Sonnet BioTherapeutics Holdings, Inc.A Award	Chief Medical Officer	AAward	+8,000 sh	—	—	9,374
2025-06-30	Sonnet BioTherapeutics Holdings, Inc.WarrantA Award	Chief Medical Officer	AAward	+86.5K sh	—	—	86,505
2023-12-11	Sonnet BioTherapeutics Holdings, Inc.A Award	Chief Medical Officer	AAward	+1,271 sh	—	—	1,374
2023-01-07	Sonnet BioTherapeutics Holdings, Inc.D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−14.6K sh	—	—	3,571
2023-01-07	Sonnet BioTherapeutics Holdings, Inc.A Award	Chief Medical Officer	AAward	+14.6K sh	—	—	18,198
2022-12-14	Sonnet BioTherapeutics Holdings, Inc.A Award	Chief Medical Officer	AAward	+14.6K sh	—	—	64,627
2021-06-09	Sonnet BioTherapeutics Holdings, Inc.P Purchase	Chief Medical Officer	PPurchase	+15K sh	$1.54	+$23.1K	50,000
2021-05-19	Sonnet BioTherapeutics Holdings, Inc.P Purchase	Chief Medical Officer	PPurchase	+10K sh	$1.55	+$15.5K	35,000
2021-03-25	Sonnet BioTherapeutics Holdings, Inc.A Award	Chief Medical Officer	AAward	+25K sh	—	—	25,000
2016-01-04	IMMUNE DESIGN CORP.A Award	Chief Medical Officer	AAward	+7,000 sh	—	—	7,522
2016-01-04	IMMUNE DESIGN CORP.Employee Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+30K sh	—	—	30,000
2015-10-30	IMMUNE DESIGN CORP.Employee Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+40K sh	—	—	40,000
2015-01-07	IMMUNE DESIGN CORP.Employee Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+30K sh	—	—	30,000

Recent filings

Accepted (ET)
Dec 44
Kenney Richard T0001493152-25-026217
SEC(opens sec.gov)
Aug 214
Kenney Richard T0001641172-25-025100
SEC(opens sec.gov)
Jul 154
Kenney Richard T0001641172-25-019781
SEC(opens sec.gov)
Dec 54
Kenney Richard T0001493152-24-048953
SEC(opens sec.gov)
Feb 174
Kenney Richard T0001493152-23-005469
SEC(opens sec.gov)
Dec 224
Kenney Richard T0001493152-22-036312
SEC(opens sec.gov)
Jun 94
Kenney Richard T0001493152-21-013939
SEC(opens sec.gov)
May 204
Kenney Richard T0000905718-21-000714
SEC(opens sec.gov)
Apr 14
Kenney Richard T0000905718-21-000515
SEC(opens sec.gov)

Companies

Address

C/O IMMUNE DESIGN CORP. 1616 EASTLAKE AVE. E, SUITE 310

SEATTLE, WA, 98102